Complementary Western blot analyses, exemplified by four individual patient pairs, consistently revealed higher MZT2B protein expression in the tumor specimens, providing initial evidence of concordant protein upregulation (Fig. 4B). The gene discussed is MZT2B; the disease is neoplasm.